Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05057312 · ClinicalTrials.gov registry record · NA

Promoting HPV Vaccination Among Young Adults in Texas

A NA study of Human Papillomavirus Infection, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
1,200
Enrollment target
1
Study location

NCT05057312: Active NA study of Human Papillomavirus Infection, sponsored by M.D. Anderson Cancer Center.

NCT05057312 is a NA study of Human Papillomavirus Infection that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,200 participants, roughly in line with the 1,248-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05057312, a NA study of Human Papillomavirus Infection, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.

Interventions

  • OTHER Interview
  • OTHER Informational Intervention
  • OTHER Enhancing Accessibility to Health Care

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2021-07-26
Est. Completion 2026-07-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05057312

The ClinicalTrials.gov registry entry for NCT05057312 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,248-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Papillomavirus Infection appearing as the primary indexed condition, and to 3 interventions - of which Interview is the first listed.

NCT05057312 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05057312 about?

NCT05057312 is a clinical study titled "Promoting HPV Vaccination Among Young Adults in Texas". This clinical trial studies how to improve the human papillomavirus (HPV) vaccination rate in young adults in Texas. This trial aims to learn more about how researchers and health care providers can increase HPV vaccination among college students.

What is the current status of trial NCT05057312?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2021-07-26. Estimated completion is 2026-07-31.

What conditions does trial NCT05057312 study?

This clinical trial studies the following conditions: Human Papillomavirus Infection.

What interventions are being tested in trial NCT05057312?

The interventions under investigation include: Interview (OTHER), Informational Intervention (OTHER), Enhancing Accessibility to Health Care (OTHER).

Who is sponsoring clinical trial NCT05057312?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05057312 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Human Papillomavirus Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.